Smoking is a common habit linked to numerous health risks, affecting multiple body systems and increasing various disease risks, including respiratory and cardiovascular issues. It also triggers inflammatory reactions by affecting the immune system with harmful tobacco chemicals like nicotine and polycyclic aromatic hydrocarbons.

Smoking's impact on autoimmune skin conditions varies; it typically worsens diseases like psoriasis and hidradenitis suppurativa but shows mixed effects on others like pemphigus vulgaris and Behçet’s disease, where symptoms sometimes decrease in smokers. Interestingly, conditions like Parkinson’s disease and ulcerative colitis also show reduced associations with smoking.

A specific study noted that current smokers had a surprisingly reduced risk of developing vitiligo, a condition involving the loss of skin pigmentation due to melanocyte destruction. This could be related to tobacco’s inhibitory effects on monoamine oxidase (MAO), although further research is needed to clarify this mechanism.

Despite some findings suggesting protective effects against certain conditions, the overall negative health impacts of smoking far outweigh these benefits. Therefore, smoking should not be considered a preventive or therapeutic measure for vitiligo or any other health condition.

Suggested reading

• Relationship Between Smoking and Vitiligo
• Impact of Diet and Nutrition on Vitiligo
• Surprising Link Between Exercise and Vitiligo Management